Cognis signs new Tonalin CLA deal in Norway, Sweden

By staff reporter

- Last updated on GMT

Related tags Nutrition Linoleic acid

Cognis has cleared the way for its Tonalin CLA to be sold in
supplements in health food stores in Norway and Sweden, thanks to
an exclusive sub-license agreement with Bringwell International.

Martin Weider, Cognis Health and Nutrition's business manager for North Europe, said that Bringwell is the ideal licensing partner for Tonalin CLA in Scandinavia and is "ideally placed to realise the growth potential"​.

Tonalin has previously been available in supplements in Norway through Midelfart since 1999. In fact, Tonalin CLA has its roots in the country since the patents, licensed to Cognis, are held by Natural.

CLA stands for conjucated linoleic acid, a polyunsaturated, fatty acid that occurs naturally in the human diet increase weight reduction and keep off bay fat.

Tonalin CLA is produced through a proprietary process involving safflowers. The company says that the result is the "highest quality of CLA available"​, with "the lowest amount of non-naturally occurring isomers"​.

Tonalin CLA is amongst Cognis' best performing branded ingredients. The company said at the end of last year that, together with sterols, it helped offset the impact of falling vitamin E sales for the company.

Although the private equity-owned company released no figures about Tonalin sales at the time, it seems that the branding campaign is paying off.

In Finland it was selected as 'Health Product of the Year 2006' by the Finnish Health Food Shop-Keeping Association, which also praised the science-based consumer-facing marketing programme.

Last year Tonalin CLA was voted 'Product of the Year' in a poll of Spanish consumers, following the introduction of a line of enriched milk, yogurt and juice products by the Spanish company Corporación Alimentaria Peñasanta, under the brand name of NaturLinea.

Sales during the first nine months of 2005 at Cognis' Nutrition and Health unit were up 5.8 per cent over the prior same period, at €229 m.

Related news

Show more

Related products

show more

Nextida: Precision where it matters

Nextida: Precision where it matters

Content provided by Rousselot | 01-Jun-2024 | Product Brochure

NEXTIDA™ is an innovative platform of specific collagen peptide compositions with new targeted health benefits. Built and backed by science, Nextida stands...

Related suppliers

Follow us


View more